a 🧵on the excitement and value of Basic Science, DNA replication and repair, teamwork and collaboration, and the fundamental incompatibility of LEGO and DUPLO 1/n
as a clinician scientist, a common question from those around me, as summarised by my son, is :
"why are you going in to work at the lab when you could be saving lives RIGHT NOW in the hospital?" 2/n
as an aside, childhood mortality is thankfully very low in the UK, mainly due to improvements in perinatal care (largely driven by midwives #washyourhands#RIPSemmelweis) and advances in vaccinations (more on this later) 3/n
as a second aside, progress made in reducing childhood mortality is now stagnating, probably as a result of underinvestment in children's services and growing socioeconomic inequality ons.gov.uk/peoplepopulati… 4/n
these sentiments are echoed by my clinical colleagues, who throughout the course of the research described in this thread consistently made their feelings known in post-talk feedback 5/n
so why bother? 6/n
for me, the strongest reason to invest in investigating the incredible complexity of the world around us is that we have no way of predicting of what will be useful for us in 50, 100 or 200 years time 7/n
take as an example a development which has helped to drag (some countries) out the Covid-19 pandemic: mRNA vaccines nejm.org/doi/full/10.10… 8/n
where do we start with the foundations for these? 9/n
the work described in our paper is based on 4 interesting studies published in 2011, 2012 & 2015
the first 2, both published in 2011, and looking at yeast, described an unusual pattern of mutations associated with retained ribonucleotides in DNA pubmed.ncbi.nlm.nih.gov/21700875/ 16/n
and related to topoisomerase 1 activity; researchers described an increase in short deletions at tandem repeats 17/n
the third paper, with the incomparable @MartinReijns as its first author sciencedirect.com/science/articl…, showed that every time a mammalian cell divides, an estimated 1,000,000 ribonucleotides are incorporated and then removed by an enzyme called RNase H2 18/n
the fourth paper is a beautiful study from Sparks and Burgers showing the mechanism by which topoisomerase 1 activity leads to short deletions by its action on retained ribonucleotides embopress.org/doi/full/10.15… 19/n
all getting a bit too technical?
here is beginner's introduction, courtesy of @r0bah0lic 20/n
in living organisms, the main carriers of genetic information are DNA (LEGO) and RNA (DUPLO); they are similar but also fundamentally different 21/n
when new DNA is made, RNA is occasionally misincorporated: pieces of DUPLO end up in the LEGO.
If you try this at home, you'll see that they can fit together, but not particularly well 22/n
luckily there is an enzyme called RNAse H2 which removes the pesky DUPLO/RNA 23/n
however if RNAse H2 is absent, DUPLO/RNA can accumulate, leading to unstable structures 24/n
these can be resolved by another enzyme called topoisomerase 1, although this is a messy process and can lead to permanent changes in the order of the LEGO: mutations 25/n
our big question was whether the process that had been seen in yeast also takes place in human cells 26/n
our work shows that it does, linking topoisomerase 1 activity to a mutational signature called ID4 27/n
in cancer cells and also in the germline, potentially explaining some of the harmful mutations that lead to human diseases, and the variation seen in human populations today 28/n
but more fundamentally, it overturns the assumed mechanism for these types of mutations, polymerase slippage, a view which has been held since the 1960s pubmed.ncbi.nlm.nih.gov/5237214/ 31/n
time will tell whether these findings will change how we do things in the future, but the fundamental point is this:
we can't predict which work will be impactful or which won't, and we shouldn't let this stop us exploring the world around us 32/n
in addition huge thanks to the ever reliable @BretherickA for computational expertise @kudlalab whose door was always open for a chat @EcatTrack & @wellcometrust for funding and support @BoxtelLab for sharing sequence data
+many others too numerous to name 35/n
really such a privilege and pleasure to be part of the scientific endeavour END
• • •
Missing some Tweet in this thread? You can try to
force a refresh
interesting paper (with excellent editorial from Jianzhi Zhang nature.com/articles/d4158…) that proposes an "adaptive mutation bias" reducing mutation rates in functionally constrained regions of the genome
as Jianzhi Zhang points out, there are two logical possibilities here: 1) natural selection might lead to the evolution of machinery that reduces mutations in essential genes/regions, where a mutation is highly likely to be deleterious 2/4
or 2) reduced mutagenesis might be intrinsic to features associated with essential coding regions, or just a by-product of other biological processes 3/4
my article on childhood viral respiratory diseases is now out @RoyalSocBiorsb.org.uk/biologist-feat… (delighted to be sandwiched in between a piece on oxylipins and another on latent lepidopterans)🧵
the #BronchSTART study dashboard beta.microreact.org/project/cTkH24… already contains a huge amount of data
and you can see that there have been unusual regional variations in the RSV season this year 🧵 1/n
normally the RSV season starts in the urban centres of the NW of England and London at around the same time thorax.bmj.com/content/75/3/2… and spreads to the rest of the country in the following 3 weeks 2/n
this year, like in previous ones, RSV did start (early? late?) in the urban centres of the NW of England and peaked at epidemiological week 30 3/n
a few months ago, a group of us, reading reports of unusual patterns of RSV circulation in Australia (a "winter in summer" ncbi.nlm.nih.gov/pmc/articles/P…)
wondered whether the same might happen this year in the United Kingdom and Ireland 🧵1/n
the premise was simple: could we use a simple online questionnaire, collecting only non-patient identifiable information,
to better understand the geographical dynamics and clinical manifestations of RSV circulation in 2021/22?
It turns out we can 2/n
thanks to BronchSTART, a study powered by hundreds of clinicians in Emergency Departments, working as part of the PERUKI Network, we can now watch this year's RSV epidemic play out in real time 3/n
a lot of interest in my thread describing the impact of RSV this year on infants and children in the UK
and questions about whether children are more at risk from RSV or COVID-19 (new🧵) 1/n
RSV (respiratory syncytial virus) is an RNA virus that causes upper and lower respiratory tract infections in children
our recently published review in Vaccine pubmed.ncbi.nlm.nih.gov/33895016/ gives an in-depth introduction to the epidemiology and virology 2/n
In the average year many thousands of children across the UK develop RSV infection: in 2016 there were 36,028 admissions for children <5 in England thorax.bmj.com/content/thorax…@PHardelid with around ~700 intensive care admissions 3/n
just finished nights on call, and found that a toxic triad of RSV, rhinovirus and SARS-CoV-2 is starting to stretch the Scottish hospital I work in to its limits
it's only August
what went wrong? 🧵1/n
Problem 1. We failed to contain SARS-CoV-2. 2/n
This is a Problem for 3 reasons.
Firstly, there are the (very) small number of children with serious SARS-CoV-2 infection. 3/n